SB1282 Summary - Synthetic Drugs and Analogs

• Amends Illinois Controlled Substances Act to redefine "controlled substance analog" by replacing the requirement that it be "intended for human consumption" with a requirement that it is not FDA-approved or, if approved, not dispensed/possessed in accordance with state and federal law.

• Adds synthetic cannabinoids, piperazines, and cathinones as chemical structural classes to Schedule I controlled substances, including specific compounds like JWH-018, JWH-073, and various naphthylmethylindoles, phenylacetylindoles, benzoylindoles, and cyclohexylphenols.

• Includes synthetic cathinones derived from 2-aminopropan-1-one (excluding bupropion) with modifications through ring substitution, alkyl substitution at the 3-position, or nitrogen atom substitution with various groups.

• Modifies the definition of "controlled substance" (Section 102) to explicitly include synthetic drugs enumerated as scheduled drugs, broadening the scope of what qualifies as a controlled substance under state law.

• Establishes that controlled substance analogs are treated the same as the controlled substances they resemble for purposes of criminal penalties under Sections 401 and 402.